Follow
Daniella Rylander Ottosson
Daniella Rylander Ottosson
Doktor i neurobiologi, Lunds universitet
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
D Rylander, M Parent, SS O'Sullivan, S Dovero, AJ Lees, E Bezard, ...
Annals of neurology 68 (5), 619-628, 2010
2652010
Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson’s disease
A Kirkeby, S Nolbrant, K Tiklova, A Heuer, N Kee, T Cardoso, ...
Cell stem cell 20 (1), 135-148, 2017
2132017
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling
D Rylander, A Recchia, F Mela, A Dekundy, W Danysz, MA Cenci
Journal of Pharmacology and Experimental Therapeutics 330 (1), 227-235, 2009
2022009
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
D Rylander, H Iderberg, Q Li, A Dekundy, J Zhang, H Li, R Baishen, ...
Neurobiology of disease 39 (3), 352-361, 2010
1762010
In vivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry
O Torper, DR Ottosson, M Pereira, S Lau, T Cardoso, S Grealish, ...
Cell reports 12 (3), 474-481, 2015
1572015
The “motor complication syndrome” in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration
HS Lindgren, D Rylander, KE Ohlin, M Lundblad, MA Cenci
Behavioural brain research 177 (1), 150-159, 2007
1232007
Direct reprogramming of resident NG2 glia into neurons with properties of fast-spiking parvalbumin-containing interneurons
M Pereira, M Birtele, S Shrigley, JA Benitez, E Hedlund, M Parmar, ...
Stem cell reports 9 (3), 742-751, 2017
842017
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3, 4-dihydroxyphenylalanine-induced dyskinesia
S Schuster, E Doudnikoff, D Rylander, A Berthet, I Aubert, C Ittrich, ...
Biological psychiatry 65 (6), 518-526, 2009
842009
REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and‐independent pathways
J Drouin‐Ouellet, S Lau, PL Brattås, D Rylander Ottosson, K Pircs, ...
EMBO molecular medicine 9 (8), 1117-1131, 2017
832017
Huntingtin aggregation impairs autophagy, leading to Argonaute-2 accumulation and global microRNA dysregulation
K Pircs, R Petri, S Madsen, PL Brattås, R Vuono, DR Ottosson, I St-Amour, ...
Cell reports 24 (6), 1397-1406, 2018
652018
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia
MA Cenci, KE Ohlin, D Rylander
Parkinsonism & related disorders 15, S59-S63, 2009
632009
Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain
M Pereira, U Pfisterer, D Rylander, O Torper, S Lau, M Lundblad, ...
Scientific reports 4 (1), 1-10, 2014
542014
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action
H Iderberg, D Rylander, Z Bimpisidis, MA Cenci
Experimental neurology 250, 116-124, 2013
452013
Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum
P Aldrin-Kirk, A Heuer, DR Ottosson, M Davidsson, B Mattsson, ...
Neurobiology of disease 109, 148-162, 2018
412018
Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors
S Lau, DR Ottosson, J Jakobsson, M Parmar
Cell reports 9 (5), 1673-1680, 2014
402014
Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia
HS Lindgren, D Rylander, H Iderberg, M Andersson, SS O'Sullivan, ...
Journal of Parkinson's disease 1 (4), 347-357, 2011
402011
Constitutively active SMAD2/3 are broad-scope potentiators of transcription-factor-mediated cellular reprogramming
T Ruetz, U Pfisterer, B Di Stefano, J Ashmore, M Beniazza, TV Tian, ...
Cell Stem Cell 21 (6), 791-805. e9, 2017
312017
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism
D Rylander, V Bagetta, V Pendolino, E Zianni, S Grealish, F Gardoni, ...
Proceedings of the National Academy of Sciences 110 (46), E4375-E4384, 2013
292013
The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery
D Rylander
Parkinsonism & Related Disorders 18, S126-S128, 2012
212012
Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
T Malmlöf, D Rylander, RG Alken, F Schneider, TH Svensson, MA Cenci, ...
Experimental neurology 225 (2), 408-415, 2010
212010
The system can't perform the operation now. Try again later.
Articles 1–20